The CB2R–OX2R heteromer as a new therapeutic target to combat Alzheimer’s disease
Summary of the work awarded with the first prize of the First edition of the UB Dr. Antoni i Subirana Chair Award for Research in Pharmacology for the best Master's Degree in Research in Pharmacology at the University of Barcelona
| Author: | |
|---|---|
| Format: | report |
| Status: | Published version |
| Publication Date: | 2025 |
| Country: | España |
| Institution: | Universidad de Barcelona |
| Repository: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:dnet:ubarcelona__::51f9986ef733e9dcd26a26baa344c3f8 |
| Online Access: | https://hdl.handle.net/2445/228684 |
| Access Level: | Open access |
| Keyword: | Malaltia d'Alzheimer Farmacologia Alzheimer's disease Pharmacology |
| Summary: | Summary of the work awarded with the first prize of the First edition of the UB Dr. Antoni i Subirana Chair Award for Research in Pharmacology for the best Master's Degree in Research in Pharmacology at the University of Barcelona |
|---|